Introduction {#s1}
============

Reproduction is energetically costly. Mothers can adjust their energy balance to maximise their reproductive success through well-established neural mechanisms that match food intake to their enhanced energy requirements ([@bib68]). However, less well-understood changes also occur in many animals during reproduction; internal organs, such as the liver, pancreas, and gastrointestinal tract, increase their size and adapt their physiology, potentially contributing to an increased generation and delivery of nutrients ([@bib29]; [@bib79]).

Establishment of a positive energy balance may be particularly important to animals with a reproductive strategy that involves rapid production of large numbers of progeny. *Drosophila melanogaster* females can lay up to 100 eggs per day at the peak of their fertility in early life ([@bib20]; [@bib37]). We hypothesised that such demands may rely on major regulatory responses, which are amenable to genetic investigation in this model system. A network of organs and tissues in *Drosophila* perform many of the same basic functions as those found in mammals ([@bib59]), so we sought to explore the nature and significance of organ plasticity during reproduction.

Results {#s2}
=======

The adult midgut is remodelled in female flies after mating {#s2-1}
-----------------------------------------------------------

Female flies undergo multiple post-mating adaptations including changes in digestive physiology ([@bib19]). This prompted us to characterise possible intestinal changes occurring during the phase of peak fertility ([@bib20]; [@bib37]). We focused on the midgut epithelium because of its major digestive/absorptive roles ([@bib44]). In the midgut epithelium, long-lived progenitors (intestinal stem cells (ISCs)) divide to self-renew and to give rise to committed progenitors (called enteroblasts (EBs)), which directly differentiate into two types of progeny: absorptive enterocytes (ECs) and enteroendocrine cells (EECs) ([@bib33]). We found that mating increases the number of both dividing and differentiating midgut cells, as revealed by phospho-Histone H3 (pH3) stainings and temporal analyses of progenitors and their descendants using the dual-labelling system *escargot*-Repressible Dual Differential Marker (*esgReDDM*, [@bib3]) ([Figure 1A,C,E](#fig1){ref-type="fig"}). The midgut of mated females also becomes visibly larger; gut diameter measurements were suggestive of a net increase in the number of postmitotic intestinal cells ([Figure 1B,D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}): an increase that we confirmed by cell number and density counts ([Figure 1F](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Concurrent with midgut re-sizing, we observed mating-dependent activation of the single *Drosophila* homologue of the mammalian family of sterol regulatory element-binding proteins (SREBPs \[[@bib81]; [@bib74]; [@bib73]\], also known as *HLH106* in flies, [Figure 2A,B](#fig2){ref-type="fig"}), using a reporter subject to the same physiologically regulated proteolytic processing as wild-type SREBP ([@bib41]). SREBP activation after mating was accompanied by upregulation of midgut transcripts involved in fatty acid synthesis and activation (*SREBP*, the long-chain fatty acid CoA ligases *bubblegum* (*bgm*) and *Acyl-CoA synthetase long-chain* (*Acsl*) and, depending on genetic background, *Fatty acid synthase* (*FAS*) and *Acetyl-CoA carboxylase* (*ACC*)) ([Figure 2E,F](#fig2){ref-type="fig"}), many of which are known SREBP targets in flies and/or mammals ([@bib73]; [@bib32]). Immunohistochemical analyses using reporters pointed to the ECs located in the posterior midgut region (R5, [@bib11]; [@bib47]) as preferential sites of transcriptional and SREBP activity changes ([Figure 2A--D](#fig2){ref-type="fig"}). Thus, in female flies actively engaged in reproduction, changes in both intestinal progenitors and their progeny parallel those observed in mammals leading to hyperplasia ([@bib29]; [@bib79]), increased organ size ([@bib29]; [@bib79]) and upregulation of lipid gene expression ([@bib4]).10.7554/eLife.06930.003Figure 1.Mating increases ISC proliferation and gut size.(**A**, **A′**) Using the *esgReDDM* tracer ([@bib3]), intestinal progenitors (intestinal stem cells (ISCs) and enteroblasts) are labelled with GFP and RFP, whereas the postmitotic progeny (enterocytes (ECs) and enteroendocrine cells) that these progenitors give rise to in a defined time window is labelled with RFP only (see Supplemental Information for additional details). At 3 days after mating, the posterior midgut of mated flies contains more newly generated postmitotic progeny (**A**) compared to age-matched virgins (**A′**). It has also become visibly larger (**B**, **B′**). At this time point, these guts also have a higher number of nuclei marked by the mitotic marker pH3 in both *w*^*1118*^ and OregonR backgrounds (**C**, p = 0.008, and **E**, p \< 0.001, negative binomial GLM), although the proliferation increase is transient (data not shown). The size increase is quantified in the posterior midgut by measuring midgut diameter (**D**, p \< 0.001, t-test) and counting the number of cells labelled by the EC marker *caudal*-*Gal4* (**F**, p = 0.02, t-test). See [Table 1](#tbl1){ref-type="table"} for full genotypes.**DOI:** [http://dx.doi.org/10.7554/eLife.06930.003](10.7554/eLife.06930.003)10.7554/eLife.06930.004Figure 1---figure supplement 1.Mating re-sizes the Drosophila gut.The increase in gut size at 3 days after mating is also measurable (**A**, **A′**) and significant (**B**, p \< 0.001, t-test) in the OregonR background. The *esgReDDM* tracing system reveals that mated guts contain more cells generated in the last 7 days if the fly had been mated in that time (**C**, p \< 0.001, t-test) than if it had not. The size increase is not due to stretching of the tissue, as the density of nuclei in the posterior midgut remains the same (**D**, p = 0.77, t-test). See [Table 1](#tbl1){ref-type="table"} for full genotypes.**DOI:** [http://dx.doi.org/10.7554/eLife.06930.004](10.7554/eLife.06930.004)10.7554/eLife.06930.005Figure 2.Mating changes the activity and/or expression of lipid metabolism genes in the intestine.At 3 days after mating, increased expression of a reporter that replicates the transcriptional regulation and post-translational modification of sterol regulatory element-binding protein (SREBP) is apparent in the posterior midgut (**A**, **A′**, quantified in **B**, p \< 0.001, Mann--Whitney test). A *bgm* transcriptional reporter is also increased specifically in the ECs of the posterior midgut following mating (**C**, **C′**, quantified in **D**, p = 0.002, Mann--Whitney test). Transcript abundance of *SREBP*, *bgm*, and the *SREBP* targets *Acyl-CoA synthetase long-chain (Acsl)*, *Fatty acid synthase (FAS)*, and *Acetyl-CoA carboxylase (ACC)* is increased by mating in either one or both of the *w*^*1118*^ and OregonR backgrounds (**E** *w*^*1118*^: p = 0.02 *SREBP*, p = 0.02 *bgm*, p = 0.005 *Acsl*, p = 0.5 *FAS*, p = 0.3 *ACC*; **F** OregonR: p = 0.02 *SREBP*, p = 0.03 *bgm*, p = 0.03 *Acsl*, p = 0.01 *FAS*, p = 0.04 *ACC*, paired one-tailed t-test). See [Table 1](#tbl1){ref-type="table"} for full genotypes.**DOI:** [http://dx.doi.org/10.7554/eLife.06930.005](10.7554/eLife.06930.005)

Intestinal remodelling is mediated by increased levels of circulating juvenile hormone {#s2-2}
--------------------------------------------------------------------------------------

Female flies change their physiology and behaviour (e.g., by increasing egg production and food intake) in response to male-derived peptides acquired during mating ([@bib14]; [@bib7]). The synthesis of juvenile hormone (JH) in the *corpus allatum*, an endocrine gland, can be stimulated ex vivo by the male-derived Sex Peptide, suggesting regulation by mating ([@bib55]). Using rapid direct analysis in real time (DART) mass spectrometry, we profiled haemolymph of both virgin and mated female flies and established that the levels of in vivo circulating JH are indeed increased after mating ([Figure 3A](#fig3){ref-type="fig"}). The levels of two other juvenoid compounds, JH3-bisepoxide (JH3B) and methylfarnesoate (MF), were too low to be detected. We cannot, however, rule out that they also are regulated by mating and contribute to signalling through the JH pathway ([@bib89]; [@bib82]; [@bib85]). JH has been shown to sustain ovarian maturation through pleiotropic actions on adipose and reproductive tissues ([@bib25]), but its intestinal roles remain to be established. Consistent with a possible intestinal role, we detected transcript upregulation of the JH target *Kruppel homolog 1* (*Kr-h1*) ([@bib34]) in guts of mated females ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). To explore the roles of JH signalling on intestinal remodelling, we first fed methoprene, a JH analogue (JHa) ([@bib16]), to virgin female flies. This led to effects on intestinal progenitors, gut diameter, and lipid metabolism comparable to those triggered by mating ([Figure 3B--E,H](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). We next blocked endogenous JH production by mis-expressing the protein phosphatase inhibitor *NiPp1* using the *corpus allatum*-specific driver *Aug21-Gal4* ([@bib77]): a genetic manipulation known to result in adult-specific ablation of the *corpus allatum* and a dramatic reduction of JH titres in the haemolymph ([@bib88]). Depletion of systemic JH prevented mating-triggered remodelling: a phenotype that could be restored in these gland-ablated flies by JHa feeding ([Figure 3F,I](#fig3){ref-type="fig"}).10.7554/eLife.06930.006Figure 3.Systemic JH secreted after mating acts directly in the intestinal epithelium to drive reproductive remodelling.Circulating juvenile hormone (JH) is elevated after mating in the haemolymph of female flies (**A**, p = 0.02 at 24 hr, p = 0.002 at 48 hr, t-test with Holm\'s correction). Increased tissue renewal (**B**, **B′**) and SREBP activation (**C**, **C′**, quantified in **D**, p \< 0.001, Mann--Whitney test) are apparent following a 3-day dietary supplementation with JH analogue (JHa). JHa treatment is sufficient to increase mitoses (**E**, p \< 0.001, negative binomial GLM) and size (**H**, p \< 0.001, t-test) of the posterior midgut. Conversely, when the endogenous JH source is genetically ablated by means of *Aug21 \> NiPp1* ([@bib88]), the proliferation and size increase that follow mating are abolished, although they can be reinstated by feeding JHa (proliferation **F**, p \< 0.001 between *Aug21/+* and *Aug21 \> NiPp1* mated, p \< 0.001 between *Aug21 \> NiPp1* and *NiPp1/+* mated, p \< 0.001 between *Aug21 \> NiPp1* and *Aug21 \> NiPp1* + JHa mated; all relevant comparisons between virgins are not significant, negative binomial GLM with Holm\'s correction; gut diameter **I**, p = 0.002 between *Aug21/+* and *Aug21 \> NiPp1* mated, p \< 0.001 between *Aug21 \> NiPp1* and *NiPp1/+* mated, p \< 0.001 between *Aug21 \> NiPp1* and *Aug21 \> NiPp1* + JHa mated; all relevant comparisons between virgins are not significant, t-test with Holm\'s correction). Downregulation of either *gce* or *Met* in adult progenitors abrogates post-mating proliferation (**G**, p \< 0.001 between *esgReDDM/+* and *esgReDDM \> gce RNAi* mated, p \< 0.001 between *esgReDDM/+* and *esgReDDM \> Met RNAi* mated, negative binomial GLM with Holm\'s correction) and gut size increase (**J**, p \< 0.001 between *esgReDDM/+* and *esgReDDM \> gce RNAi* mated, p \< 0.001 between *esgReDDM/+* and *esgReDDM \> Met RNAi* mated, t-test with Holm\'s correction). The upregulation of *bgm* reporter upon mating is abolished by the downregulation of *gce*, but not *Met*, in ECs using the EC-specific driver *Mex-Gal4* (**K**--**K′′′′**). See [Table 1](#tbl1){ref-type="table"} for full genotypes.**DOI:** [http://dx.doi.org/10.7554/eLife.06930.006](10.7554/eLife.06930.006)10.7554/eLife.06930.007Figure 3---figure supplement 1.Intestinal JH signalling is relayed through Kr-h1 and underlies mating-dependent intestinal growth and gene expression phenotypes.JHa application in virgin females results in a net growth of the gut, as shown by the increase in *caudal*-marked cells (**A**, p = 0.004, t-test). The JH signalling pathway can be targeted using RNAi constructs against the receptors *Met* and *gce*, which decrease transcript abundance compared to a *tub*^*ts*^ control when expressed globally in larvae for 3 hr at 29°C (**B**, p = 0.002 for *Met*, p = 0.005 for *gce*, paired one-tailed t-test). Consequently, using *esgReDDM* to specifically knockdown *gce* in adult intestinal progenitor cells abolishes the proliferative effect of JHa application (**C**, **C′**), but does not reduce the number of progenitors after 7 days of downregulation (**D**, p \> 0.05, t test). Progenitors in which *gce* is downregulated can still proliferate normally to replenish a gut damaged by a 24 hr application of the toxin paraquat (**E**, **E′** with quantification of mitoses in **F**, p \< 0.001 for both *esgReDDM/+* and *esgReDDM \> gce RNAi*, p \> 0.05 for all other relevant comparisons, t test with Holm\'s correction) and the number of progenitors is not reduced by this treatment (**G**, p = 0.04 between *esgReDDM/+* untreated control and *esgReDDM \> gce RNAi* untreated control, p \> 0.05 for all other relevant comparisons, t test with Holm\'s correction). The transcription factor *Kruppel homolog 1* (*Kr-h1*), a well-established effector of JH responses, is transcriptionally upregulated after 3 days of mating (**H**, p = 0.02 in *w*^*1118*^, p = 0.02 in OregonR, paired two-tailed t-test). *Kr-h1* function is necessary and sufficient for the re-sizing of the gut after mating, as its downregulation in intestinal progenitors through RNA interference using *esgReDDM* prevents the increase in proliferation (**I**, p \< 0.001 between *esgReDDM/+* and *esgReDDM \> Kr-h1 RNAi* mated, negative binomial GLM with Holm\'s correction) and gut size (**J**, p \< 0.001 between *esgReDDM/+* and *esgReDDM \> Kr-h1 RNAi* mated, t-test with Holm\'s correction) typically observed after 7 days of mating, while overexpression of *Kr-h1* constructs from the same cells recapitulates the effect of mating in virgins (proliferation, **I**, p \< 0.001 between *esgReDDM/+* and *esgReDDM \> Kr-h1*~*GS*~ virgin, p \< 0.001 between *esgReDDM/+* and *esgReDDM \> Kr-h1*~*UAS*~ virgin, negative binomial GLM with Holm\'s correction; gut size **J**, p \< 0.001 between *esgReDDM/+* and *esgReDDM \> Kr-h1*~*UAS*~ virgin, t-test with Holm\'s correction). RNAi constructs against *Kr-h1* and *SREBP* are effective in downregulating these genes; they decrease transcript abundance compared to a *tub*^*ts*^ control when expressed globally in larvae for 3 hr at 29°C (**K**, p = 0.02 for *Kr-H1*, p \< 0.001 for both *SREBP* constructs, paired one-tailed t-test). Downregulating *gce* constitutively from ECs using *Mex-Gal4* significantly suppresses the transcriptional increase of the lipid metabolism gene *bgm* upon mating, as indicated by the intensity ranking of a *gce* reporter (**L**, p = 0.004 between *gce RNAi/+* and *Mex \> gce RNAi*, p = 0.02 between *Mex \> gce RNAi* and *Mex/KK control*, Mann--Whitney test with Holm\'s correction; relevant comparisons with *Met RNAi* are not significant). See [Table 1](#tbl1){ref-type="table"} for full genotypes.**DOI:** [http://dx.doi.org/10.7554/eLife.06930.007](10.7554/eLife.06930.007)

JH signals directly to adult intestinal progenitors and enterocytes via Met and Gce receptors {#s2-3}
---------------------------------------------------------------------------------------------

To establish the cellular targets of JH and its mode of action, we interfered with JH signalling in a cell-autonomous manner in the intestine. We used the *esgReDDM* system, based on the widely used *esg-Gal4* driver ([@bib50]), to target both classes of intestinal progenitor cells (ISCs and EBs). We first confirmed that expression of RNAi transgenes against either of the two previously identified JH receptors *Methoprene-tolerant* (*Met*) or *germ cell-expressed bHLH-PAS* (*gce*) ([@bib34]; [@bib34a]) resulted in a significant reduction in their transcript levels ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). We then confined expression of these RNAi transgenes against *Met*, *gce*, or their target *Kr-h1* to adult intestinal progenitors using *esgReDDM*. Downregulation of any of these three genes fully prevented both the proliferative response to mating and midgut re-sizing, whereas overexpression of *Kr-h1* led to mating-like responses in virgin females ([Figure 3G,J](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), indicating direct actions of JH on intestinal progenitors. Intestinal progenitors with downregulated JH receptors were found in numbers comparable to those of controls in virgin females and were able to increase their proliferation in response to a JH-unrelated stimulus: the ROS-inducing compound paraquat ([@bib8]) ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). This indicates that they remain competent to respond to the well-studied homeostatic machinery that maintains gut integrity ([@bib33]), and suggests that mating- and damage-induced proliferative mechanisms may differ and can be uncoupled. In ECs, targeted by the specific driver *Mex-Gal4* ([@bib63]), only downregulation of *gce* strongly reduced the mating-dependent upregulation of a *bgm* reporter ([Figure 3K](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Together, these findings show that intestinal remodelling results from a rise in systemic JH triggered by mating. JH signals directly to intestinal progenitors to yield a larger organ in a *Met* and *gce*-dependent manner. Acting predominantly through *gce*, JH also adjusts gene expression in ECs to support increased lipid metabolism.

Mating-triggered intestinal remodelling enhances reproductive output {#s2-4}
--------------------------------------------------------------------

Intestinal remodelling during reproduction could result from increased nutrient intake ([@bib58]) or utilisation by the developing offspring. Alternatively, it may occur in preparation for, but be uncoupled from, such nutritional demands. Consistent with the latter idea, the mating-triggered changes in proliferation, midgut size, and SREBP activity are all still apparent in sterile female *ovo*^*D1*^ mutant flies in which egg production is blocked prior to vitellogenesis and which do not increase food intake after mating ([@bib7]) ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). To investigate the significance of intestinal remodelling, we used several RNAi transgenes to downregulate either the JH receptors or *SREBP*, which is activated by mating, specifically in adult ECs. In all cases, EC-specific downregulation led to a reduction in the number (but not viability) of eggs produced ([Figure 4E,F](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), indicating that JH signalling is required to specifically enhance the quantity (fecundity), but not the quality (viability), of reproductive output. Progenitor cell-specific downregulation may also be expected to reduce fecundity; however, we detected expression of several intestinal progenitor drivers outside the intestine (data not shown), which could affect egg production independently of the intestine. More specific tools will be necessary to resolve this important issue.10.7554/eLife.06930.008Figure 4.Metabolic remodelling of ECs by JH sustains reproduction.Lipid-harbouring tissues (fat body, posterior midgut, and ovary) are found in close proximity in the fly\'s abdomen (represented schematically in **A**, and in confocal microscopy in **D**). The amount of stored triglycerides (TAG) in the carcass of 3-day mated sterile female flies is increased compared to virgins (**B**, p = 0.003 in *w*^*1118*^, p = 0.009 in OregonR, t-test), as quantified by thin-layer chromatography (**C**). Adult-specific downregulation of JH receptors *gce* and *Met* or *SREBP* in ECs reduces the total progeny produced by females in the 6 days following their first mating (**E**, p = 0.01 between *Met RNAi/+* and *Mex*^*ts*^ *\> Met RNAi*, p = 0.007 between *Mex*^*ts*^ *\> Met RNAi* and *Mex*^*ts*^*/KK* control, p \< 0.001 between *gce RNAi/+* and *Mex*^*ts*^ *\> gce RNAi*, p = 0.007 between *Mex*^*ts*^*\> gce RNAi* and *Mex*^*ts*^*/KK* control; **F** p = 0.04 between *SREBP RNAi/+* and *Mex*^*ts*^ *\> SREBP RNAi*, p = 0.04 between *Mex*^*ts*^ *\> SREBP RNAi* and *Mex*^*ts*^*/TRiP* control, t-test with Holm\'s correction). In the absence of the ovarian lipid sink in sterile *ovo*^*D1*^ virgin flies, treatment with JHa increases neutral lipid content, as revealed by Oil Red O staining, in the posterior midgut (**G**, **G′**, quantified in **H**: p = 0.002, t-test). Acute block of lipid export by heat-shock activation of *lpp \> stop \> LTP RNAi* ([@bib60]) in virgin females results in heavy accumulation of neutral lipid in this gut region, further indicating that this midgut region provides a net source of lipid in adult flies (**I**, quantified in **J**: p \< 0.001 between *LTP RNAi/+* and *lpp \> stop \> LTP RNAi*, p \< 0.001 between *lpp \> stop \> LTP RNAi* and *lpp \> stop\>/+*, p \< 0.001 between *lpp \> stop \> LTP RNAi* and *lpp \> stop \> LTP RNAi* heat shock control, t-test with Holm\'s correction). See [Table 1](#tbl1){ref-type="table"} for full genotypes.**DOI:** [http://dx.doi.org/10.7554/eLife.06930.008](10.7554/eLife.06930.008)10.7554/eLife.06930.009Figure 4---figure supplement 1.Reproductive intestinal remodelling is uncoupled from germline demands and is needed to sustain reproduction.Sterile females carrying the *ovo*^*D1*^ mutation experience the post-mating increase in progenitor proliferation (**A**, p \< 0.001 for *w*^*1118*^ and *ovo*^*D1*^, negative binomial GLM, visualised in **C** and **C′** using the *esgReDDM* tracing system), gut size increase (**B**, p \< 0.001 for *w*^*1118*^ and *ovo*^*D1*^, t-test), and *SREBP* reporter activation (**D**, p \< 0.001 for *w*^*1118*^ and p = 0.005 for *ovo*^*D1*^, Mann--Whitney test, visualised in **E** and **E′**). The role of intestinal remodelling in enhancing reproductive capacity is confirmed with additional RNA interference lines against the JH receptor *gce* (chosen because of its larger effect in [Figure 4E](#fig4){ref-type="fig"}; **F**, p = 0.002 between *GD11178/+* and *Mex*^*ts*^*\> GD11178*, p = 0.008 between *Mex*^*ts*^ *\> GD11178* and *Mex*^*ts*^*/+*, p \< 0.001 between *GD47465/+* and *Mex*^*ts*^*\> GD47465*, p = 0.003 between *Mex*^*ts*^ *\> GD11178* and *Mex*^*ts*^*/+*, t-test with Holm\'s correction) and *SREBP* (**G**, p = 0.008 between *GD37641/+* and *Mex*^*ts*^ *\> GD37641*, p \< 0.001 between *GD37640/+* and *Mex*^*ts*^ *\> GD37640*, t-test). Despite these effect on fecundity, eggs laid by *gce*, *Met*, or *SREBP* RNAi mothers are viable (**H** and **I**, mean hatched fraction \>0.9 for all groups, p \> 0.05 for all relevant comparisons, t-test). See [Table 1](#tbl1){ref-type="table"} for full genotypes.**DOI:** [http://dx.doi.org/10.7554/eLife.06930.009](10.7554/eLife.06930.009)

The anatomical proximity between the ovary and the posterior midgut region where changes in lipid gene expression and activity take place ([Figure 4A,D](#fig4){ref-type="fig"}) raises the intriguing possibility that enhanced nutrient delivery from the intestine to the ovary may occur locally, to maximise loading into eggs. As the trafficked nutrients would be therefore released in the form of eggs, we used sterile *ovo*^*D1*^ females to quantify lipid content, reasoning that it might accumulate in gut and/or peripheral fat stores in the absence of the local ovarian sink ([@bib62]). Consistent with this idea, sterile *ovo*^*D1*^ female flies accumulate peripheral fat after mating ([Figure 4B,C](#fig4){ref-type="fig"}), and lipid accumulation in the posterior midgut could be induced in fertile flies by either treatment of these sterile flies with JHa or by knocking down lipid shuttling proteins acutely, thereby blocking all lipid circulation ([@bib60]) ([Figure 4G--J](#fig4){ref-type="fig"}). Together, these data show that the metabolic reprogramming of ECs by JH supports fecundity, thus confirming that intestinal plasticity is required to sustain reproductive output at the time of peak fertility. The importance of intestinal lipogenesis is becoming increasingly recognised in both flies and mammals ([@bib46]; [@bib60]; [@bib76]; [@bib78]), and here we show that it underpins reproductive output. Notably, upregulation of *SREBP* target genes has been reported in the small intestine of lactating rats ([@bib4]), suggesting that our findings may be conserved beyond insects.

Discussion {#s3}
==========

Intestinal remodelling and the costs of reproduction {#s3-1}
----------------------------------------------------

The onset of reproduction involves a significant shift in metabolic demands, now routed towards the growing offspring as well as the mother. *Drosophila* may experience a particularly extreme example of this shift after mating: an event that enhances egg production tenfold and triggers multiple metabolic and behavioural adaptations ([@bib40]; [@bib69]; [@bib5]; [@bib19]). These changes are in large part brought about by signals delivered by the male during copulation, in particular the Sex Peptide ([@bib40]; [@bib5]). Several reports connect SP to the *corpus allatum* and JH production ([@bib55]; [@bib10]), suggesting that the systemic effects of mating via SP could be carried out through this pathway. Intriguingly, both JH knockdown in females ([@bib88]) and SP deficiency in males ([@bib86]) extend female lifespan while reducing reproductive output and/or peak fertility. This 'cost of mating' on lifespan is not relieved by sterility ([@bib83]), suggesting that physiological effects in non-reproductive tissues are responsible. The intestinal reprogramming that we describe here represents a novel physiological target of postmating plasticity ideally placed at the interface between nutrition and reproduction. Ageing in flies is accompanied by reduced fertility ([@bib21]) and intestinal dysplasia ([@bib8]; [@bib18]), and genetic manipulations that affect intestinal progenitors can affect lifespan ([@bib9]; [@bib66]). Thus, it will be informative to explore the links between JH-triggered postmating responses in lifespan, age-dependent intestinal and reproductive dysfunction, and lifetime fertility.

Hormonal remodelling of adult organs {#s3-2}
------------------------------------

In larvae, the *corpora allata* integrate age and metabolic status information to optimise developmental progression ([@bib53]; [@bib71]). Increasing evidence is revealing that, in adults, this insect endocrine organ acts as a nexus that detects changes in the organism\'s circumstances and condition to alter its metabolic and/or reproductive set points. It does so through regulated release of JH, with pleiotropic effects on ovarian maturation, adipose tissue, learning and memory, diapause, innate immunity, and ageing ([@bib57]; [@bib35]; [@bib22]; [@bib87]; [@bib25]; [@bib67]; [@bib88]). Some of these effects may be modulated by crosstalk between JH and other systemic signals such as insulin-like peptides and ecdysteroids ([@bib34]; [@bib39]; [@bib54]; [@bib65]), but the cellular and molecular targets of JH action remain incompletely understood. Our findings have uncovered a direct and functionally significant effect on adult organ plasticity by showing that JH promotes proliferation and resets gut size through its actions on intestinal progenitors and activates expression of lipid metabolism genes in ECs. Based on structural and functional similarities, insect JH has been compared to mammalian thyroid hormones ([@bib24]): key energy balance regulators often associated with gastrointestinal alterations when pathologically dysregulated ([@bib51]). Given the well-established changes in thyroid function during human pregnancy ([@bib26]), it will therefore be of interest to explore their contribution to reproductive intestinal remodelling. Downstream of its receptor(s), relay of JH signalling in the intestine may differ from the classical model in which *Met* and *gce* act redundantly ([@bib1]; [@bib34]). Indeed, downregulation of either gene alone is sufficient to prevent the mating-induced changes in intestinal progenitors: a finding that we confirmed by observing that viable *Met*^*27*^ mutants also fail to undergo mating-induced remodelling (data not shown). The actions of Met and Gce may also be cell-specific, as suggested by a preferential requirement for *gce* in ECs, and may result from different Met/gce expression levels (our unpublished observations) and/or interacting partners. Candidates to consider include Taiman, homologous to the mammalian steroid receptor coactivator 1 (SRC-1)/NCoA-1/p160 ([@bib17]; [@bib45]; [@bib90]) and, more intriguingly, circadian clock proteins: Met-binding partners recently shown to coordinate the switch from diapause to reproduction in other insects ([@bib75]; [@bib6]).

Adult organ plasticity, obesity, and cancer {#s3-3}
-------------------------------------------

Adult organ plasticity is not a peculiarity of *Drosophila* reproduction; examples of changes in intestinal size and nutrient utilisation are widespread across the animal kingdom in response to both environmental and internal challenges ([@bib13]; [@bib29]; [@bib64]; [@bib79]; [@bib58]). Although intestinal remodelling has not been assessed in human pregnancy, it could be one of the major drivers for the changes in gut microbiota observed during pregnancy ([@bib38]) and could contribute to changes in gastrointestinal physiology, common during pregnancy ([@bib36]). Resetting of anatomical or metabolic features of internal organs may thus be a broadly used strategy to achieve a positive energy balance which, when matched to the developing offspring\'s demands, will contribute to reproductive success. However, if deployed in the absence of such demands, organ remodelling could contribute to the weight gain and increased fat mass that has been observed upon gonadectomy of multiple species including mice, rats, cats, monkeys, and other mammals ([@bib30] and references therein). In a more physiological context, inappropriate persistence of such metabolic remodelling beyond pregnancy and lactation could similarly contribute to post-pregnancy weight retention in humans---a phenotype that, at least in mice, is correlated with enhanced intestinal function ([@bib15]; [@bib27]). Similarly, inappropriate persistence of JH-like mechanisms that change the homeostatic set point of adult stem cells and their progeny to transform an organ may also help explain why pregnancy changes the susceptibility to certain cancers ([@bib28]).

Materials and methods {#s4}
=====================

Fly strains {#s4-1}
-----------

For wild-type experiments, the genetic backgrounds *w*^*1118*^, OregonR, and CantonS were used as indicated in the figures and/or full genotypes list ([Table 1](#tbl1){ref-type="table"}). The following transgenic and mutant stocks were used: *esg-Gal4* (Bloomington, unknown insertion), *tub-Gal80* (Bloomington 7018, [@bib49]), *UAS-mCD8::GFP* (Bloomington 5130, [@bib43]), *UAS-H2B::RFP* (presumed from [@bib42]), *caudal-Gal4* (insertion used in [@bib70]), *SREBP-Gal4* (Bloomington 38395, [@bib41]), *bgm-lacZ* (Bloomington 28120, [@bib52]), *Aug21-Gal4* (Bloomington 30137, [@bib77]), *UAS-NiPp1* (Bloomington 23712, [@bib61]), *tub-Gal4* (Bloomington 5138, [@bib43]), *Mex-Gal4* ([@bib63]), *UAS-Kr-h1* (DGRC 120052, referred to as *UAS-Kr-h1*), *ovo*^*D1*^ ([@bib12]), *hs-FLP; lpp-Gal4* and *UAS \> stop \> LTP RNAi* stocks (both from [@bib60]). RNAi constructs were obtained from VDRC for *gce* (KK101814, GD11178 and GD47465), *Met* (KK100638), *Kr-h1* (KK107935), and *SREBP* (GD37641 and GD37640), as well as the genetically matched KK control (KK60100); and from the Bloomington TRiP collection for *SREBP* (34073) and the genetically matched TRiP control (GFP in valium10, 35786). Because the control stocks are generated in the same background as the *RNAi* lines used, the *Gal4* parental control (e.g., *yv; Mex-Gal4/+; tub-Ga80*^*ts*^*/UAS-GFP*) is genetically matched to the experimental genotype (e.g., *yv; Mex-Gal4/+; tub*-*Gal80*^*ts*^*/UAS-SREBP RNAi TRiP*). The line referred to as *UAS-Kr-h1*~*GS*~ is *GS(2)73ES2b*, which was isolated in a genetic screen for enhancer/suppressors of a large-eye phenotype caused by Dl overexpression in the Dominguez lab. Genomic DNA flanking the P-element insertions in the *GS(2)73ES2b* stock were recovered by inverse PCR and sequenced. A BLAST search with the obtained sequence produced perfect matches to the genomic region upstream of the *Kr-h1* gene (26B5 Chromosome 2L: 6,082,603,\...,6,096,498).10.7554/eLife.06930.010Table 1.Full genotypes**DOI:** [http://dx.doi.org/10.7554/eLife.06930.010](10.7554/eLife.06930.010)Genotype in text/figureFull genotypeFigure panel(s)*esgReDDMw; esg-Gal4, UAS-mCD8::GFP/+; tub-Gal80*^*ts*^*, UAS-H2B::RFP/+; +*[Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1C,D](#fig1s1){ref-type="fig"}, [Figure 3B](#fig3){ref-type="fig"}*w*^*1118*^ background*w*^*1118*^*; +; +; +*[Figure 1B--D](#fig1){ref-type="fig"}, [Figure 2E](#fig2){ref-type="fig"}, [Figure 3E,H](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1H](#fig3s1){ref-type="fig"}, [Figure 4---figure supplement 1A,B](#fig4s1){ref-type="fig"}OregonR background*+; +; +; +*[Figure 1E](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1A,B](#fig1s1){ref-type="fig"}, [Figure 2F](#fig2){ref-type="fig"}, [Figure 3---figure supplement 1H](#fig3s1){ref-type="fig"}*caudal \> H2B::RFPw; caudal-Gal4/+; UAS-H2B::RFP/+; +*[Figure 1F](#fig1){ref-type="fig"}, [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}*SREBP \> CD8::GFPw/+; SREBP-Gal4/+; UAS-CD8::GFP/+; +*[Figure 2A,B](#fig2){ref-type="fig"}, [Figure 3C,D](#fig3){ref-type="fig"}, [Figure 4D](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}*bgm-lacZw/+; bgm-lacZ/+; +; +*[Figure 2C,D](#fig2){ref-type="fig"}CantonS background*+; +; +; +*[Figure 3A](#fig3){ref-type="fig"}*Aug21/+w; Aug21-Gal4/+; +; +*[Figure 3F,I](#fig3){ref-type="fig"}*Aug21 \> NiPp1w; Aug21-Gal4/+; UAS-NiPp1/+; +*[Figure 3F,I](#fig3){ref-type="fig"}*NiPp1/+w; +; UAS-NiPp1/+; +*[Figure 3F,I](#fig3){ref-type="fig"}*esgReDDM/+w; esg-Gal4, UAS-mCD8::GFP/+; tub-Gal80^ts^, UAS-H2B::RFP/+; +*[Figure 3G,J](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1D,F,G,I,J](#fig3s1){ref-type="fig"}*esgReDDM \> gce RNAiw; esg-Gal4, UAS-mCD8::GFP/UAS-gce RNAi KK101814;* *tub-Gal80^t^^s^*, *UAS-H2B::RFP/+; +*[Figure 3G,J](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1C--G](#fig3s1){ref-type="fig"}*esgReDDM \> Met RNAiw; esg-Gal4, UAS-mCD8::GFP/UAS-Met RNAi KK100638;* *tub-Gal80*^*ts*^*, UAS-H2B::RFP/+; +*[Figure 3G,J](#fig3){ref-type="fig"}*esgReDDM \> Kr-h1 RNAiw; esg-Gal4, UAS-mCD8::GFP/UAS-Kr-h1 RNAi KK107935;* *tub-Gal80*^*ts*^*, UAS-H2B::RFP/+; +*[Figure 3---figure supplement 1I,J](#fig3s1){ref-type="fig"}*esgReDDM \> Kr-h1*~*GS*~*w; esg-Gal4, UAS-mCD8::GFP/UAS-Kr-h1*~*GS*~*;tub*-*Gal80*^*ts*^, *UAS-H2B::RFP/+; +*[Figure 3---figure supplement 1I](#fig3s1){ref-type="fig"}*esgReDDM \> Kr-h1*~*UAS*~*w; esg-Gal4, UAS-mCD8::GFP/UAS-Kr-h1*~*UAS*~*;* *tub-Gal80^ts^, UAS-H2B::RFP/+; +*[Figure 3---figure supplement 1I,J](#fig3s1){ref-type="fig"}*tub*^*ts*^*\> Met RNAiw; tub-Gal80^ts^/UAS-Met RNAi KK100638;* *tub-Gal4, UAS-mCD8::GFP/+; +*[Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}*tub*^*ts*^ *\> gce RNAiw; tub-Gal80^ts^/UAS-gce RNAi KK101814;* *tub-Gal4, UAS-mCD8::GFP/+; +*[Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}*tub*^*ts*^ *\> Kr-h1 RNAiw; tub-Gal80^ts^/UAS-Kr-h1 RNAi KK107935;* *tub-Gal4, UAS-mCD8::GFP/+; +*[Figure 3---figure supplement 1K](#fig3s1){ref-type="fig"}*tub*^*ts*^ *\> SREBP RNAi GDw; tub-Gal80^ts^/UAS-SREBP RNAi GD37640;* *tub-Gal4, UAS-mCD8::GFP/+; +*[Figure 3---figure supplement 1K](#fig3s1){ref-type="fig"}*tub*^*ts*^ *\> SREBP RNAi TRiPw; tub-Gal80^ts^* *+; tub-Gal4, UAS-mCD8::GFP/UAS-SREBP RNAi TRiP34073; +*[Figure 3---figure supplement 1K](#fig3s1){ref-type="fig"}*tub*^*ts*^*/+w; tub-Gal80^ts^/+; tub-Gal4, UAS-mCD8::GFP/+; +*[Figure 3---figure supplement 1B,K](#fig3s1){ref-type="fig"} (control)*Met RNAi/+w; bgm-lacZ/UAS-Met RNAi KK100638; +; +*[Figure 3K](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1L](#fig3s1){ref-type="fig"}*Mex \> Met RNAiw; Mex-Gal4, bgm-lacZ/UAS-Met RNAi KK100638; +; +*[Figure 3K](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1L](#fig3s1){ref-type="fig"}*gce RNAi/+w; bgm-lacZ/UAS-gce RNAi KK101814; +; +*[Figure 3K](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1L](#fig3s1){ref-type="fig"}*Mex \> gce RNAiw; Mex-Gal4, bgm-lacZ/UAS-gce RNAi KK101814; +; +*[Figure 3K](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1L](#fig3s1){ref-type="fig"}*Mex/KK* control*w; Mex-Gal4, bgm-lacZ/attp40; +; +*[Figure 3K](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1L](#fig3s1){ref-type="fig"}*ovo*^*D1*^ (*w*^*1118*^ background)*w*^*1118*^*; +; ovo*^*D1*^*/+; +*[Figure 4C](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1A,B](#fig4s1){ref-type="fig"}*ovo*^*D1*^ (OregonR background)*+/w*^*1118*^*; +; ovo*^*D1*^*/+; +*[Figure 4C,G,H](#fig4){ref-type="fig"}*Met RNAi/+w; UAS-Met RNAi KK100638/+; +; +*[Figure 4E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1H](#fig4s1){ref-type="fig"}*Mex*^*ts*^*\> Met RNAiw; Mex-Gal4/UAS-Met RNAi KK100638; tub-Gal80^ts^/+; +*[Figure 4E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1H](#fig4s1){ref-type="fig"}*gce RNAi/+w; UAS-gce RNAi KK101814/+; +; +*[Figure 4E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1H](#fig4s1){ref-type="fig"}*Mex*^*ts*^ *\> gce RNAiw; Mex-Gal4/UAS-gce RNAi KK101814; tub-Gal80*^*ts*^*/+; +*[Figure 4E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1H](#fig4s1){ref-type="fig"}*Mex*^*ts*^*/KK* control*w; Mex-Gal4/attp40; tub-Gal80*^*ts*^*/+; +*[Figure 4E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1H](#fig4s1){ref-type="fig"}*SREBP RNAi/+w/y, v; +; UAS-SREBP RNAi 34073; +*[Figure 4F](#fig4){ref-type="fig"}*Mex*^*ts*^*\> SREBP RNAiw/y, v; Mex-Gal4/+; tub-Gal80*^*TS*^*/UAS-SREBP RNAi 34073; +*[Figure 4F](#fig4){ref-type="fig"}*Mex*^*ts*^*/TRiP* control*w/y, v; Mex-Gal4/+; tub-Gal80*^*ts*^*/UAS-GFP; +*[Figure 4F](#fig4){ref-type="fig"}*hs-FLP lpp \> stop \> LTP RNAiw, hs-FLP/w; lpp-Gal4/+; UAS \> stop \> LTP RNAi/+; +*[Figure 4I,J](#fig4){ref-type="fig"}*UAS \> stop \> LTP RNAi/+w; +; UAS \> stop \> LTP RNAi/+; +*[Figure 4J](#fig4){ref-type="fig"}*hs-FLP lpp/+w, hs-FLP/w; lpp-Gal4/+; +; +*[Figure 4J](#fig4){ref-type="fig"}*esgReDDM/ovo*^*D1*^*ovo*^*D1*^*/w; esg-Gal4, UAS-mCD8::GFP/+;* *tub-Gal80*^*ts*^*, UAS-H2B::RFP/+; +*[Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}*SREBP \> CD8::GFP/ovo*^*D1*^*w/+; SREBP-Gal4/+; UAS-CD8::GFP/ovo^D1^; +*[Figure 4---figure supplement 1D,E](#fig4s1){ref-type="fig"}*gce RNAi GD11178/+w; UAS-gce RNAi GD11178; +; +*[Figure 4---figure supplement 1F](#fig4s1){ref-type="fig"}*Mex*^*ts*^*\> gce RNAi GD11178w; Mex-Gal4/UAS-gce RNAi GD11178; tub-Gal80*^*ts*^*/+; +*[Figure 4---figure supplement 1F](#fig4s1){ref-type="fig"}*gce RNAi GD47465/+w; +; UAS-gce RNAi GD47465/+; +*[Figure 4---figure supplement 1F](#fig4s1){ref-type="fig"}*Mex*^*ts*^*\> gce RNAi GD47465w; Mex-Gal4/+; tub-Gal80*^*ts*^*/UAS-gce RNAi GD47465; +*[Figure 4---figure supplement 1F](#fig4s1){ref-type="fig"}*Mex*^*ts*^*/+w; Mex-Gal4/+; tub-Gal80^ts^+; +*[Figure 4---figure supplement 1F](#fig4s1){ref-type="fig"}*SREBP RNAi GD37641/+w; UAS-SREBP RNAi GD37641/+; +; +*[Figure 4---figure supplement 1G,I](#fig4s1){ref-type="fig"}*Mex*^*ts*^*\> GD37641w; Mex-Gal4/UAS-SREBP RNAi GD37641; tub-Gal80*^*ts*^*/+; +*[Figure 4---figure supplement 1G,I](#fig4s1){ref-type="fig"}*SREBP RNAi GD37640/+w; UAS-SREBP RNAi GD37640/+; +*[Figure 4---figure supplement 1G,I](#fig4s1){ref-type="fig"}*Mex*^*ts*^*\> RNAi GD37640w; Mex-Gal4/+; tub-Gal80*^*ts*^*/UAS-SREBP RNAi GD37640; +*[Figure 4---figure supplement 1G,I](#fig4s1){ref-type="fig"}

Fly husbandry {#s4-2}
-------------

Fly stocks were reared on a standard cornmeal/agar diet (5.5% cornmeal, 6% dextrose, 1.3% yeast, 0.55% agar supplemented with 0.18% nipagin and 2.9 ml/l propionic acid) or 'Iberian' diet (4.4% wheat flour, 6% brown sugar, 3% yeast, 1% agar supplemented with 0.04% nipagin and 7.6 ml/l of propionic acid). All experimental flies were kept at 25°C expect for those containing temperature-sensitive regulation (*tub-Gal80*^*ts*^), which were set up at 18°C (restrictive temperature) and transferred to 29°C (permissive temperature) at the time when activation was needed in the specific experiment. For all experiments, experimental and control flies were handled in parallel and experienced the same temperature shifts and treatments.

For the analysis of mating and JHa effects, virgin female flies were collected at eclosion, aged for 4--5 days on standard food and then transferred for 3 days (7 days for flies harbouring the *esgReDDM* transgenes, as these flies show a delay in mating responses at 29°C) into new tubes in the presence of wild-type males (typically 4--5 females + 6 males) or food supplemented with 1.5 mM methoprene (Sigma-Aldrich, St Louis, MO, PESTANAL 33375, racemic mixture), added to freshly prepared food when still liquid but \<50°C. This concentration was chosen in a pilot dilution test from 0.5 to 7.5 mM as the one that induced activation of the *SREBP-Gal4* reporter to levels comparable to mating, and corresponds to approximately half of the concentration used in a previous study ([@bib23]). Controls were age-matched virgin females, also transferred to new tubes for the same time but without the addition of males and/or methoprene.

For the paraquat experiments, virgin female flies were raised at 18°C and aged for 4--5 days after eclosion, at which point they were starved for 4 hr without water. The flies were then transferred to vials containing filter paper soaked in 5% sucrose with or without 10 mM paraquat dichloride (Sigma-Aldrich). After spending 24 hr at 29°C in these vials, their midguts were dissected and stained for pH3 as described before.

Antibodies {#s4-3}
----------

The following antibodies were used: rabbit anti-pH3 (1:2000, Upstate, Merck-Millipore, Germany), sheep anti-GFP (1:1000, Biogenesis, for *esgReDDM* staining), goat anti-GFP (1:1500, Abcam, UK, for *SREBP \> mCD8::GFP* staining), rabbit anti-β-galactosidase (1:5000, MP Biomedicals, Santa Ana, CA); secondary antibodies were either FITC/Cy3 conjugates from Jackson ImmunoResearch (1:200, West Grove, PA, for *SREBP \> mCD8::GFP* and *bgm-lacZ*) or Alexa488/647 conjugates from Invitrogen Life Technologies (1:1000, Carlsbad, CA, for *esgReDDM* and *caudal \> H2B::RFP*). Preparations for proliferation analysis were counterstained with DAPI (Sigma-Aldrich) and mounted in Fluoromount-G (Southern Biotech, Birmingham, AL). Preparations for reporter analysis were mounted in Vectashield with DAPI (Vector Labs, Burlingame, CA).

Proliferation and size quantifications {#s4-4}
--------------------------------------

Quantification of mitoses in wild-type and *ovo*^*D1*^ female flies was carried out by counting individual nuclei marked by the mitotic marker pH3 using a Nikon Eclipse 90i Fluorescence microscope through a 40× objective. For the acquisition of gut images in these samples, a single 1392 × 1040 field was acquired posterior to the midgut--hindgut boundary using QCapture software (QImaging). Progeny dynamics were analysed using the *esgReDDM* system ([@bib3]), which has the genetic makeup *esg-Gal4, UAS-mCD8::GFP; tub-Gal80*^*ts*^*, UAS-H2B::RFP*. At the permissive temperature of 29°C, the GFP reporter is expressed in *esg-Gal4* positive cells (ISCs and EBs), but due to the perdurance of the RFP-tagged histone H2B::RFP the *esg-Gal4-*negative progeny (including ECs and EECs) generated from these progenitors since the shift to permissive temperature is additionally labelled in red. To restrict progeny analysis to mating-induced changes, *esgReDDM* flies were maintained at 18°C, such that Gal4 expression is suppressed by *tub-Gal80*^*ts*^, and moved to 29°C only at the time of mating. After 3 days of mating at 29°C, guts were dissected and stained for GFP and pH3 (the endogenous RFP signal was detected directly). EC number in the posterior midgut was assessed by imaging the entire gut of *caudal \> H2B::RFP* flies and counting the number of RFP-marked cells. Confocal images were obtained with a Leica TCS SP5 inverted confocal microscope using a 20× air objective for *esgReDDM* and a 10× air objective for *caudal \> H2B::RFP*. Stacks were typically collected every 1 µm, and the images (1024 × 1024) were reconstructed using maximum projection. Bright-field images or confocal maximum projections were loaded into ImageJ ([@bib72]) and the line tool used to quantify the width of the gut across the centre of the image. ImageJ was also used to outline the guts of *esgReDDM* flies using the polygon tool before analysing the resulting region of interest (ROI) with a custom MATLAB (The MathWorks, Inc.) script optimised for the ReDDM method. Extended details about this analysis are available from ([@bib3]). Briefly, maximum projections were adjusted for levels and offsets and filtered to remove noise (using always the same parameters for scans within one experiment), then the area of the gut was identified by background staining and the cell nuclei by DAPI signal. The size of nuclei can be used to discriminate between diploid cells (ISCs, EBs, and EECs) and polyploid ECs. The red-labelled nuclei (persistent H2B::RFP) and green-labelled cells (mCD8::GFP) were identified by segmentation and compared to the pattern of nuclei defined by DAPI to generate a report of total ECs (large DAPI cells), total progenitors + progeny (RFP signal), total ISCs and EBs (GFP signal), and total area. The same script was also used to count the number of *caudal \> H2B::RFP* cells.

Analysis of reporter gene expression {#s4-5}
------------------------------------

For *SREBP \> mCD8::GFP* and *bgm-lacZ* experiments, confocal images were obtained with a Leica SP5 upright confocal microscope using a 20× glycerol immersion objective. A single 20× field (1024 pixels wide) immediately posterior to the midgut--hindgut boundary was acquired with a Z resolution of 1.5 µm. ImageJ was used to generate a maximum projection for each sample and all images pertaining to one experiment were loaded as separate layers into a single Adobe Photoshop CS6 file. The layers were then ranked blindly on the basis of their relative intensity in the relevant channel.

qPCR {#s4-6}
----

To quantify mating-induced changes in gene expression, posterior midguts from at least 10 adult female flies were dissected, discarding Malphigian tubules and the hindgut. To determine the knockdown efficiency of the RNAi transgenes, *tub*-*Gal80*^*ts*^*; tub-Gal4, UAS*-*GFP* was used to downregulate them ubiquitously. 8--10 third instar larvae were collected from crosses kept at 21°C and were shifted to 29°C for 3 hr to allow RNAi transgene expression. Samples (posterior midguts or whole larvae) were directly stored on dry ice and at −80°C in RNAlater TissueProtect Tubes (Qiagen, the Netherlands) until total RNA was extracted using RNeasy Mini Kit (Qiagen), from which cDNAs were prepared with SuperScript First-Strand Synthesis System (Invitrogen Life Technologies) using oligo-dT primers. Quantitative PCR was performed using the SYBR Green PCR Master Mix (Applied Biosystems Life Technologies) in a 7500 Real-Time PCR System (Applied Biosystems) using the housekeeping gene *rp49* as a control. All qPCRs were performed in triplicate and the relative expression was calculated using comparative Ct method.

Primers used:*Forward 5′--3′Reverse 3′--5′SREBP*GCAAAGTGCGTTGACATTAACCAGTGTCGTGTCCATTGCGAA*bgm*GCAATCGATTTGCGTGACCAGGCCCAGGACGATTGTAGAG*Acsl*CGGAGATCCGACAAAGCAGTTGAGCACAGCTCCTCAAAGG*FAS*GACATTCGATCGACGCCTCTGCTTTGGCTTCTGCACTGAC*ACC*AATTCTCCAAGGCTCGTCCCCATGCCGCAATTGTTTTCGC*Kr-h1*ACAATTTTATGATTCAGCCACAACCGTTAGTGGAGGCGGAACCTG*gce*AGCTGCGTATCCTGGACACTTCGAGAGCTGAAACATCTCCAT*Met*CCGCCGTCCTTAGATTCGCGTTCCCTTGAGGCCGGTTT*rp49*TGTCCTTCCAGCTTCAAGATGACCATCCTTGGGCTTGCGCCATTTGTG

Detection of circulating JH hormone by DART-MS {#s4-7}
----------------------------------------------

Haemolymph was extracted from virgin or mated females using pulled glass microcapillary needles (10 μl vol, \#2-000-010; Drummond Scientific, PA, USA). The needle tip was placed into the gap between the anepisternum and anepimeron of anesthetised flies, and haemolymph was collected using a slight vacuum (0.2--1.0 mPa) for ∼30 s. Haemolymph from 45 to 50 flies was collected in the same needle. The contents were ejected into a 0.1 ml glass vial insert (Thermo Fisher Scientific, MA, USA) by applying pressurised air (∼5--6 kPa) with a Femtojet microinjector (Eppendorf, NY, USA), and weighed prior to extraction. 20 μl of MeOH was added to the haemolymph followed by extraction with 20 μl of hexane, repeated four times. Pooled hexane extract was evaporated under a gentle stream of N~2~ and reconstituted in 10 μl of hexane. All extracts were prepared and measured immediately after collection.

Mass spectra were acquired with an atmospheric pressure ionisation time-of-flight mass spectrometer (AccuTOF-DART, JEOL USA, Inc.) equipped with a DART interface and operated with a resolving power of 6000 (FWHM definition). The RF ion guide voltage was set at 600 V. The atmospheric pressure ionisation interface potentials were as follows: orifice 1 = 15 V, orifice 2 = 5 V, ring lens = 5 V. Mass spectra were stored at a rate of one spectrum per second with an acquired m/z range of 60--1000. The DART interface was operated in positive-ion mode using helium gas with the gas heater set to 200°C. The glow discharge needle potential was set to 3.5 kV. Electrode 1 was set to +150 V, and electrode 2 was set to +250 V. Helium gas flow was set to 2.0 l/min. Calibration for exact mass measurements was accomplished by acquiring a mass spectrum of polyethylene glycol (average molecular weight 600) as a reference standard in every data file. Analysis was done with JEOL MassCenter software (version 1.3.0.1). Accurate mass measures and isotope pattern matching by MassMountaineer (FarHawk Marketing Services, Ontario, CA) were used to support elemental composition assignments.

2 μl of the haemolymph hexane extract was placed on the tip of a borosilicate glass capillary. The capillary was introduced to the DART ion source with a micromanipulator, thus allowing for reproducible placement of the sample. Each extract was measured 4--5 times. The averaged signal intensity was normalised to the total weight of the haemolymph and converted to absolute quantities after establishing a calibration curve with a JHIII standard (Santa Cruz Biotechnology, CA, USA, CAS 24198-95-6). Analysis of JHIII by DART produces two signature ions at m/z 267.20 (intact molecule) and at m/z 249.18 (loss of water), consistent with a previous study ([@bib56]). The abundance of the \[M-H~2~O + H\]^+^ signal peak was used for all measurements because the parent ion at m/z 267.20 could not be consistently resolved due to interference from other signals. To detect other juvenoid compounds, the following mass signatures were used: methylfarnesoate (\[M + H\]^+^ 251.20) and JHIII Bisepoxide (\[M + H\]^+^ 283.19). DART MS was previously shown to be an effective method for quantitative and high-sensitivity measurements of JHIII ([@bib56]).

Fecundity and egg viability experiments {#s4-8}
---------------------------------------

Flies for fecundity and egg viability experiments were raised at 18°C to prevent the expression of the RNAi transgenes during development, then shifted to 29°C in late pupariation (after ∼20 days). Virgin females were collected upon eclosion and after 4 days mated overnight to OregonR males (10 males, 10 females per vial). Males were then removed, individual female flies were transferred to a new single vial of yeast-supplemented standard food (cornmeal/agar diet with 5% yeast content) every 48 hr, and eggs were counted from the vacated vial to quantify fecundity. To assess egg viability, a fraction of the egg-containing vials were then maintained at 29°C, and the number of eclosed progeny was counted and compared with egg counts. Each genotype cross was performed three times, and egg production from each fly was assessed over three 48 hr repeats, covering a total of 6 days of egg laying.

Thin-layer chromatography (TLC) {#s4-9}
-------------------------------

Ovaries and guts were removed from flies immobilised on ice and the remaining carcasses (three flies per sample) were immediately homogenised in a mixture of methanol (60 μl), chloroform (150 μl), and water (75 μl), following previously described procedures ([@bib2]; [@bib31]). After an extraction period (1 hr at 37°C), aqueous and organic phases were separated by the addition of a 1:1 mixture of 1 M potassium chloride and chloroform (75 μl each). Samples were briefly centrifuged and 120 μl of the organic phase was transferred to fresh Eppendorf tubes and left to air-dry for 3 hr. The resulting dessicated lipids were resuspended in 16 μl of a 1:1 chloroform:methanol mixture. 3 μl of each sample was applied to TLC plates (Merck Millipore116487) and lipid species were separated by standing the plates in ∼1 cm of a mobile phase consisting of 69.5% hexane, 29.5% diethyl ether, and 1% acetic acid. Once the mobile phase had traversed the plates, they were briefly dried and then dipped in a cerium-ammonium-molybdate stain (ammonium heptamolybdate tetrahydrate 2.5 g, cerium (IV) sulphate hydrate complex with sulphuric acid 1 g, water 90 ml, sulphuric acid 10 ml). The TLC plates were developed at 80°C for 25 min and then imaged on a digital scanner. The TAG content was quantified by analysing the resulting TIFF images using the densitometry tool in ImageJ software. All reagents were purchased from Sigma-Aldrich.

Lipid export block {#s4-10}
------------------

The shuttling of lipids between organs was abolished by downregulating the apolipoprotein lipid transfer protein (LTP) through heat-shock-activated acute RNAi expression based on the pFRiPE system ([@bib48]). In the larva, this manipulation prevents the loading of gut-originated medium-chain diacylglycerides, which are a dominant component of circulating lipids, onto the haemolymph carrier Lipophorin (Lpp) and leads to the accumulation of stored lipid in the larval gut in triglyceride form ([@bib60]). The downregulation of *LTP* from the fat body driver *lpp-Gal4* was triggered in virgin females by 1 hr heat-shock at 37°C; after 6 hr, the guts were dissected for neutral lipid detection using Oil Red O staining.

Oil Red O stainings {#s4-11}
-------------------

Fly guts were dissected from flies immobilised on ice and were then fixed in a solution of 4% formaldehyde for 45 min. Guts were washed in consecutive applications of phosphate buffered saline (PBS), double-distilled water, and a 60% isopropanol solution. Oil Red O (Sigma-Aldrich) stock was prepared as a 0.1% solution in isopropanol, then a freshly prepared working solution (a 6:4 dilution in water) was added for 20 min to the guts, then washed in 60% isopropanol and water. The preparations were mounted in glycerol for analysis, and the posterior midgut was imaged using either a Zeiss Axioplan stereo microscope equipped with Nomarski optics or an Olympus BX53 phase contrast microscope equipped with a 4×/0.13 UPlanFLN lens through CellSens software (Olympus, Japan). The resulting TIFF files were analysed quantitatively using a custom ImageJ script: the gut was manually outlined as a ROI using the polygon tool, then the RGB channels were split and the red channel subtracted from the green to eliminate background (grey) signal. The mean intensity of the resulting signal within the ROI was calculated with the built-in Analyse Particles function.

Statistics and figure preparation {#s4-12}
---------------------------------

All statistical analyses were carried out in the R environment ([@bib80]). Comparisons between normally distributed groups were carried out using Student\'s *t*-test (R function t.test), unpaired, two-tailed and incorporating Welch\'s correction to account for unequal variances, followed by Bonferroni-Holm correction when multiple comparisons were applied. qPCR data were analysed comparing the housekeeping-subtracted Cts of experimentally matched virgin and mated samples, thus using paired t-test, one-tailed when confirming previous reporter experiments ([Figure 2E,F](#fig2){ref-type="fig"}), and two-tailed when no prediction could be made (panel H in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Count data with a distinctly non-normal distribution (specifically, pH3 counts) were fitted with a negative binomial model (R function glm.nb from MASS package, [@bib84]) followed by likelihood ratio tests (R function anova.negbin from MASS package). Rank-based experiments were analysed with the Mann-Whitney-Wilcoxon rank sum test (R function wilcox.test). All graphs were generated in R using a custom script based on the base boxplot function superimposed with individual data points plotted with the beeswarm function (package beeswarm). Confocal and bright-field images shown in conjunction were always acquired with the same settings as part of a single experiment. For visualisation purposes, level and channel adjustments were applied using Adobe Photoshop CS6 to the confocal images shown in figure panels (the same correction in all comparable images), but all quantitative analyses were carried out on unadjusted raw images or maximum projections. In all figures, \* indicates 0.05 \> p ≥ 0.01, \*\* indicates 0.01 \> p ≥ 0.001, and \*\*\* indicates p \< 0.0001.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "Direct endocrine remodelling of the adult intestine maximises reproductive success in *Drosophila*" for consideration at *eLife*. Your article has been favorably evaluated by Fiona Watt (Senior editor), a Reviewing editor, and two reviewers.

The Reviewing editor and the reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

The reviewers agree that this is an original, interesting and broadly convincing paper that is suitable in principle for publication in *eLife*. However, in addition to a number of minor points, there were a few more significant issues that should be addressed before the paper can be accepted.

Both the Abstract and the main text are so brief that background and experimental details are omitted. Without adding too much extra text, it should be revised so that it is a complete document. The Abstract should contain important keywords for searching.

The results shown in [Figure 3G,J](#fig3){ref-type="fig"}, in which depletion of either of the two JH receptors completely blocks ISC mitoses and gut growth, is strange enough that it might be an artefact. If these gene products are both bona fide JH receptors then we might expect them to have overlapping, redundant functions, and that depleting both (not just one) of them would be necessary to fully block JH action. The authors need to do some controls to ensure that these RNAis are not just killing the stem cells, in a JH independent manner; or they need to explain clearly why this is not necessary.

The fecundity assays should also be done with the *esgReDDM* driver to test directly the relevance of gut resizing to fertility. Without some kind of direct test, they will probably have to weaken the argument for this interesting model, which would be a pity.

To understand the corpus allatum ablation experiment, it\'s important to refer explicitly to the reduction of JH titers that this causes, as described in the [@bib88] paper.

*Reviewer \#1 minor comments*:

Title: "Direct endocrine remodeling..."---is it necessary/relevant to claim that this is direct? How can the authors be sure about this?

Title and elsewhere: "maximizes reproductive success"---maximization relative to what? To really assess this, I suppose one would need to measure reproductive success among a large number of wild-type genotypes from natural populations. Is the claim here that reproductive success is maximized/optimized in the wild-type (as measured/defined here) and that any deviation from this state reduces reproductive success? The authors should be careful with their phrasing, especially with regard to any putative adaptive interpretation of their findings. For example, in the Abstract/Summary, they state that the "midgut is dramatically remodelled to maximise reproductive success", and I am wondering how certain one can be about this rather strong claim. I would say that their results are consistent with such an adaptive interpretation but they do not prove it.

Title and elsewhere: "reproductive success"---again, here I think the authors should be a bit more careful. Many of their results pertain to fecundity rather than fertility. Reproductive success in the strict sense refers to the number of surviving offspring (thus to fertility, not to fecundity). From the Methods section it appears that the authors have indeed also measured fertility but, alas, I cannot find these data: all the plots seem to show fecundity (at least that is what the axes say), not fertility. Also note that, unlike defined in the Methods (in the subsection headed "Fertility and fecundity experiments"), viability (=egg to adult survival, which is a proportion or percentage) is *not* the same as fertility. Fertility is the number of total eggs produced times viability, giving the total number of eggs produced from which adult flies eclose. Moreover, importantly, as far as I can tell, the authors have measured fecundity only over the first 6 days of adulthood. This is hardly an accurate measure of (lifetime) reproductive success! It might very well be that minor early differences in fecundity will vanish with age so that there won\'t be any net difference between two groups claimed to be different. On the other hand, since pek fecundity is reached within 3--4 days after eclosion, the authors can argue that they have focused on the most important part of the age-dependent fecundity profile. Nonetheless, the authors should be more careful when talking about "reproductive success".

Throughout manuscript, especially in the introductory parts: The literature on the connection between fat metabolism and reproduction is not very well covered; many key references are missing. See, for example, the review by [@bib30] in Cell Metabolism and references therein. There is lots of evidence, for example, that curtailing or abolishing reproduction increases fat storage (which is not necessarily inconsistent at all with the notion that mating increases fat metabolism), and that lipids are one of the main energetic currencies of trade-offs between reproduction and somatic maintenance.

Results and Discussion: "also occur in many mammals"---rephrase perhaps, as this implies that the previous sentence was not about mammals?

Results and Discussion: "adaptations"---do the authors mean here "adaptation" in the physiological sense of the word or do they mean evolutionary adaptation? It is unclear. The authors must be careful here.

Results and Discussion, end of the first paragraph: Interestingly, both mating (as reported here) and curtailing reproduction (e.g., via gonadectomy) increase lipid levels, so have equivalent effects, and this is of course not necessarily a contradiction. Remarkably, the same appears to be true for plastic changes in organ size: similar to the increased organ size upon mating, the size of organs is sometimes also observed in some sterile fly mutants, for instance, with the fat body and the corpus allatum being hypertrophied and with transplanation of wildtype ovaries into the sterile flies restoring normal organ size (papers by Winifred Doane, cited in [@bib30]). I think that some of these connections should be discussed.

Results and Discussion, second paragraph: The results regarding JH III are very interesting, but what about the potential effects of JH3-bisepoxide and of methylfarnesoate? Potential effects of these other juvenoid compounds produced by the corpus allatum should at least be mentioned as a caveat, i.e. while JH III is clearly involved in the phenomena observed here, the authors cannot exclude effects also of JH3B and MF.

Results and Discussion, same paragraph: Was it not possible to simultaneously downregulate/silence Met and Gce? As far as I understand these two paralogs only function as an operational JH receptor in *Drosophila* as a heterodimer.

Results and Discussion, third paragraph: *ovo*^*D1*^*---*this is an interesting set of results but, as far as I can tell, the authors did not include a fertile wildtype control for *ovo*^*D1*^ in this experiment, so the only statement can be made from this experiment is about non-mating vs mating. A properly controlled experiment should include 4 groups: WT control vs *ovo*^*D1*^, both mated vs unmated.

Results and Discussion, same paragraph: "might accumulate... peripheral fat stores in the absence of the local (ovary) sink". Two reactions to this statement: (1) we already know that in many animals sterility (gonadectomy, castratation) causes increased fat accumulation or obesity (cf. [@bib30] and references therein), (2) the *ovo*^*D1*^ mutants are, as far as I know, not properly ovary-less, they just have smaller ovaries than wild-type. Thus, with regard to (1) there is indeed published evidence for the authors' statement. Similarly, the important result in [@bib88], that corpus allatum ablation impedes fat body development, should be cited and discussed. This result is consistent with the authors\' findings.

Results and Discussion: (Endcrine regulation of) Organ size plasticity in *Drosophila*---the authors should cite the papers by Alexander Shingleton here.

Results and Discussion, fourth paragraph, especially the last two sentences: this is interesting and well-written but perhaps a bit on the speculative side.

In the figure legend for [Figure 1](#fig1){ref-type="fig"} and elsewhere: what is a negative binomial ANOVA? By definition an ANOVA is general (not a generalized) linear model which assumes a normal distribution of the errors/residuals. Here the authors seem to have used a generalized linear model with a negative binomial error structure, but I cannot be sure. Please clarify.

In general: In some of their experiments, the authors have used TLC and a (semi-quantitative) quantification of TLC to assess peripheral fat. Why did the authors not use one of the well-established and commercially available kit-based TAG assays?

In the subsection headed "Fly strains": I am worried that apparently none of the experiments has involved fully co-isogenic, backcrossed wild-type controls which are co-isogenic with the *Gal4* and UAS-RNAi lines used. I think this is probably not a big concern for the majority of experiments, but this might play a role for the fecundity assays since this trait is notoriously quantitative and sensitive to genetic background.

In the subsection headed "Fly strains" and following: did the authors verify the efficiency of RNAi silencing via qRT-PCR? The fact that many manipulations did have phenotypic effects suggests that RNAi has worked but this is of course no proof. In general, I think that if one uses RNAi one should demonstrate that it has indeed reduced mRNA transcript (or even better protein levels).

In the subsection headed "Fly husbandry": methoprene---how was this dosage determined? Is the methoprene used the pure enantiomere or a racemic mixture of s- and r-methoprene? More details on the product from Sigma should be given.

In the subsection headed "Detection of circulating JH hormone by DART-MS": synthetic JH III---I am not aware that there is synthetic JH III but I may of course be wrong. Is this not simply proper JH III isolated from Manduca sexta?

In the subsection headed "Fertility and fecundity experiments" and following: I failed to find the fertility experimental data---where are these? Note (see my comment above) that viability is *not* the same as fertility. I am also a bit worried about the temperature shift effects on fecundity: this is rather unnatural. Of course I see the reason for doing this but: (1) were there no GeneSwitch-*Gal4* constructs available that could have been used to restrict silencing to the adult stage? (2) were the (wildtype) controls in these experiments also subjected to the temperature shift? Finally, as mentioned above, measuring fecundity over 6 days may not be a good, accurate predictor of (lifetime) reproductive success.

In the subsection headed "Statistics and figure preparation": I am confused about "assuming unequal deviances". Do the authors mean "variances"? "Deviances" is *not* the same as variances; deviances have a special statistical meaning which does not make sense in the context of a *t*-test. And "assuming unequal" variances does not make sense either: a *t*-test assumes normality of residuals and equal variances. Nonetheless, there is in fact a *t*-test which does not require the assumption of equal variances, the Welch *t*-test or Welch-ANOVA, but I am not sure the authors have used this.

[Figure 4A](#fig4){ref-type="fig"} strikes me as being unnecessary.

*Reviewer \#2 minor comments*:

1\) The expression patterns of the *Gal4* drivers need to be described somewhat better (preferably in brief in the main text) and supporting citations or results given. This includes *Mex-, Aug21-* and *esgReDDM-Gal4*.

2\) In [Figures 2B and 3D](#fig2 fig3){ref-type="fig"} the authors have not measured SREBP "activity" as it states in the figure, but levels. Please correct this.

10.7554/eLife.06930.012

Author response

*Both the Abstract and the main text are so brief that background and experimental details are omitted. Without adding too much extra text, it should be revised so that it is a complete document. The Abstract should contain important keywords for searching*.

Both the Abstract and the main text have been expanded. The Abstract contains keywords such as juvenile hormone, Met and Gce receptors, which were missing in the previous version. The revised main text describes additional experiments (detailed below in response to other points), and includes 39 new references, clarifications and discussions requested by the reviewers (also outlined in subsequent points). As a result, the old Results and Discussion content has been subdivided into additional sections (Results and three Discussion sections).

*The results shown in* [*Figure 3G,J*](#fig3){ref-type="fig"}*, in which depletion of either of the two JH receptors completely blocks ISC mitoses and gut growth, is strange enough that it might be an artefact. If these gene products are both bona fide JH receptors then we might expect them to have overlapping, redundant functions, and that depleting both (not just one) of them would be necessary to fully block JH action. The authors need to do some controls to ensure that these RNAis are not just killing the stem cells, in a JH independent manner; or they need to explain clearly why this is not necessary*.

We have tested this by quantifying the number of intestinal progenitors (as the number of *esgReDDM* GFP-positive cells) upon downregulation of *gce*. No changes in the number of progenitors were observed, ruling out stem cell death as a possible reason for the reduction in mitoses. This is now shown in [Figure 3--figure supplement 1](#fig3s1){ref-type="fig"}, panel D. To further confirm that the health of intestinal progenitors in which *gce* has been downregulated is not compromised, we tested their ability to respond to an unrelated proliferative stimulus by treating guts with the ROS-inducing compound paraquat (e.g. [@bib8] Cell Stem Cell). Both the number of *gce*-downregulated progenitors and their pH3 counts were comparable to those of controls in response to paraquat. These results further indicate that downregulation of JH signalling in adult intestinal progenitors does not compromise their viability or function---at least within the timeframe of our experiments---and are now shown in [Figure 3--figure supplement 1](#fig3s1){ref-type="fig"} panels E-F.

Gain-of-function experiments further show the specificity of the stem cell JH phenotypes; both methoprene treatment and overexpression of the JH target *Kr-h1* specifically in adult intestinal progenitors lead to increased proliferation/gut size in virgin females ([Figure 3E,H](#fig3){ref-type="fig"}, and [Figure 3--figure supplement 1](#fig3s1){ref-type="fig"} panels I and J respectively).

We have also used a viable *Met*^*27*^ mutant to confirm RNAi phenotypes, and to further confirm that the actions of *Met* and *gce* in the intestine are not redundant. As the box plots in [Author response image 1](#fig5){ref-type="fig"} show, the mating-induced increases in proliferation (assessed by pH3 staining) and midgut diameter do not occur in *Met*^*27*^ female flies. However, the lack of *Met* expression in these mutants is constitutive and in all tissues, and, possibly as a result, their basal intestinal proliferation and midgut size seem higher than those of wild-type flies, so we feel that the RNAi experiments described in the manuscript are more rigorously controlled for potential temporal and/or non-cell autonomous effects.10.7554/eLife.06930.013Author response image 1.**DOI:** [http://dx.doi.org/10.7554/eLife.06930.013](10.7554/eLife.06930.013)

Met has been shown to bind both itself and Gce (see [@bib34] Annual Rev Entomol 58: 181--204 for a review). Hence, it is conceivable that the mating-induced increase in ISC proliferation requires (at least transient) Met-Gce heterodimers, in light of the full phenotype resulting from depletion of either one alone. Alternatively, even if Met and Gce carry out equivalent functions independently, they may be haploinsufficient in the intestine; in this situation, a partial reduction in overall Met/Gce function resulting from loss of either gene would render the intestine unable to undergo postmating remodelling.

The intestinal progenitor quantifications, responses to paraquat and the *Kr-h1* experiments are described in the revised Results section: "Juvenile hormone signals directly to adult intestinal progenitors and enterocytes via Met and Gce receptors". The *Met*^*27*^ experiment and considerations about molecular mechanisms of Met/Gce action are discussed in the revised Discussion under "Hormonal remodelling of adult organs".

*The fecundity assays should also be done with the* esgReDDM *driver to test directly the relevance of gut resizing to fertility. Without some kind of direct test, they will probably have to weaken the argument for this interesting model, which would be a pity*.

This is a good point. Similar manipulations to those used to assess contributions of enterocytes to egg production can result in reduced egg production when confined to *esg*-positive progenitors (e.g. *esgReDDM \> Met -RNAi* or *esgReDDM \> gce-RNAi)*. However, during the course of these experiments, we also noticed that, unlike the enterocyte driver *mex-Gal4*, two routinely used *esg-Gal4* intestinal progenitor drivers are also expressed in a few cells in the ovary (see [Author response image 2](#fig6){ref-type="fig"}, images by Bruno Hudry and Jake Jacobson, Miguel-Aliaga lab). Another routinely used driver, *GS5961*, is also expressed outside the intestine (Nicholson et al (2008) Genetics 178:215) Hence, although our experiments do suggest that intestinal-progenitor-driven resizing also contributes to increased egg production, we do not feel that we can make such a statement in the manuscript, given that the driver may not be exclusively expressed in the intestine -- a finding that we mention in this revised version (last Results section). We do, however, disagree that the model is weakened as a result; the enterocyte data clearly shows that at least some of the mating-induced intestinal changes do affect egg production.10.7554/eLife.06930.014Author response image 2.**DOI:** [http://dx.doi.org/10.7554/eLife.06930.014](10.7554/eLife.06930.014)

*To understand the corpus allatum ablation experiment, it\'s important to refer explicitly to the reduction of JH titers that this causes, as described in the* [@bib88] *paper*.

The Yamamoto results are now described in the paper: when the corpus allatum ablation experiment is introduced (in the Results section "Intestinal remodelling is mediated by increased levels of circulating juvenile hormone"), in the first two sections of the Discussion and in the [Figure 3](#fig3){ref-type="fig"} legend.

Reviewer \#1 minor comments:

*Title: "Direct endocrine remodeling..."---is it necessary/relevant to claim that this is direct? How* can *the authors be sure about this*?

We conclude that the action of juvenile hormone on the intestine is direct based on the fact that 1) downregulation of the juvenile hormone receptors specifically in adult intestinal progenitors or enterocytes ([Figure 3G,J and K](#fig3){ref-type="fig"} and [Figure 3--figure supplement 1L](#fig3s1){ref-type="fig"}), and 2) activation of the pathway specifically in these cells by *Kr-h1* expression ([Figure 3--figure supplement 1 I, J](#fig3s1){ref-type="fig"}) both recapitulate phenotypes resulting from changes in systemic JH signalling and/or or JH analogue feeding. We believe that this is an important finding because it shows that intestinal remodelling is not secondary to the effects of JH on organs such as the ovary or the fat body. We do, however, agree that "direct endocrine remodelling" may not necessarily convey this information, and have revised the Title and Abstract so that "direct" is now absent from the title, but is more extensively explained in the Abstract.

*Title and elsewhere: "maximizes reproductive success"---maximization relative to what? To really assess this, I suppose one would need to measure reproductive success among a large number of wild-type genotypes from natural populations. Is the claim here that reproductive success is maximized/optimized in the wild-type (as measured/defined here) and that any deviation from this state reduces reproductive success? The authors should be careful with their phrasing, especially with regard to any putative adaptive interpretation of their findings. For example, in the Abstract/Summary, they state that the "midgut is dramatically remodelled to maximise reproductive success", and I am wondering how certain one* can *be about this rather strong claim. I would say that their results are consistent with such an adaptive interpretation but they do not prove it*.

We did not mean to imply success in ecological/evolutionary terms, but acknowledge that the phrasing may be misleading. Therefore, we have amended the relevant sentences and have replaced "success" throughout the manuscript with more neutral/generic ("reproductive output"), or specific/descriptive (e.g. "egg production at the time of peak fertility") terms throughout the manuscript. We have also included two additional paragraphs (Introduction, second paragraph, and Discussion, first section in the revised manuscript) providing more information regarding the dynamics of egg production in *Drosophila*, and discussing possible long-term effects of intestinal remodelling on reproductive output.

We have also replaced the word "maximise" with "sustain" or "enhance" throughout the manuscript.

*Title and elsewhere: "reproductive success"---again, here I think the authors should be a bit more careful. Many of their results pertain to fecundity rather than fertility. Reproductive success in the strict sense refers to the number of surviving offspring (thus to fertility, not to fecundity). From the Methods section it appears that the authors have indeed also measured fertility but, alas, I cannot find these data: all the plots seem to show fecundity (at least that is what the axes say), not fertility. Also note that, unlike defined in the Methods (in the subsection headed "Fertility and fecundity experiments"), viability (=egg to adult survival, which is a proportion or percentage) is* not *the same as fertility. Fertility is the number of total eggs produced times viability, giving the total number of eggs produced from which adult flies eclose. Moreover, importantly, as far as I* can *tell, the authors have measured fecundity only over the first 6 days of adulthood. This is hardly an accurate measure of (lifetime) reproductive success! It might very well be that minor early differences in fecundity will vanish with age so that there won\'t be any net difference between two groups claimed to be different. On the other hand, since pek fecundity is reached within 3-4 days after eclosion, the authors* can *argue that they have focused on the most important part of the age-dependent fecundity profile. Nonetheless, the authors should be more careful when talking about "reproductive success"*.

All instances of reproductive success have now been amended as described above. In addition, we now provide additional data showing a specific effect of these genetic manipulations on egg production rather than egg quality/viability ([Figure 4--figure supplement 1](#fig4s1){ref-type="fig"}, panels H and I), and explain these terms whenever they are used in the revised manuscript.

*Throughout manuscript, especially in the introductory parts: The literature on the connection between fat metabolism and reproduction is not very well covered; many key references are missing. See, for example, the review by* [@bib30] *in Cell Metabolism and references therein. There is lots of evidence, for example, that curtailing or abolishing reproduction increases fat storage (which is not necessarily inconsistent at all with the notion that mating increases fat metabolism), and that lipids are one of the main energetic currencies of trade-offs between reproduction and somatic maintenance*.

We apologise for this oversight. The links between reproduction, lipid metabolism and ageing are more extensively discussed in the revised manuscript (first and third Discussion sections).

*Results and Discussion, first paragraph: "also occur in many mammals"---rephrase perhaps, as this implies that the previous sentence was not about mammals*?

"Mammals" has been replaced with "animals".

*Results and Discussion: "adaptations"---do the authors mean here "adaptation" in the physiological sense of the word or do they mean evolutionary adaptation? It is unclear. The authors must be careful here*.

We meant physiological adaptations. We have replaced "possible intestinal adaptations" with "possible intestinal changes occurring during the phase of peak fertility".

*Results and Discussion, end of the first paragraph: Interestingly, both mating (as reported here) and curtailing reproduction (e.g.,* via *gonadectomy) increase lipid levels, so have equivalent effects, and this is of course not necessarily a contradiction. Remarkably, the same appears to be true for plastic changes in organ size: similar to the increased organ size upon mating, the size of organs is sometimes also observed in some sterile fly mutants, for instance, with the fat body and the corpus allatum being hypertrophied and with transplanation of wildtype ovaries into the sterile flies restoring normal organ size (papers by Winifred Doane, cited in* [@bib30]*). I think that some of these connections should be discussed*.

Hansen et al. is now mentioned in the revised manuscript. However, we feel that there is a difference between the hypertrophy examples listed by the reviewer (which may passively result, for example, from increased stores in the case of the fat body) and the organ resizing we have reported, which involves an increase in the number of cells and reprogramming of their metabolic state driven by active signals.

*Results and Discussion, second paragraph: The results regarding JH III are very interesting, but what about the potential effects of JH3-bisepoxide and of methylfarnesoate? Potential effects of these other juvenoid compounds produced by the corpus allatum should at least be mentioned as a caveat, i.e. while JH III is clearly involved in the phenomena observed here, the authors cannot exclude effects also of JH3B and MF*.

We looked for signals corresponding to JH3-bisepoxide and methylfarnesoate in the hemolymph extracts and were unable to detect them, suggesting that their concentration is very low. However, the review is right that we cannot formally exclude effects from these two juvenoid compounds and we now mention this explicitly in the revised manuscript (in the Results section "Intestinal remodelling is mediated by increased levels of circulating juvenile hormone X" and in the Materials and methods section "Detection of circulating JH hormone by DART-MS").

*Results and Discussion, same paragraph: Was it not possible to simultaneously downregulate/silence Met and Gce? As far as I understand these two paralogs only function as an operational JH receptor in Drosophila as a heterodimer*.

We did not see this as a priority because, as discussed earlier, downregulation of either receptor alone fully prevented the mating-triggered increase in proliferation and resizing. Furthermore, although Met can bind itself and Gce, these dimers dissociate in the presence of methoprene or JHIII. Currently available data suggests that Met may mediate its actions by interaction with other nuclear proteins such as Taiman (see [@bib34] Annu Rev Entomol for a comprehensive review). Given the different effects of *Met* and *gce* downregulation on enterocytes and stem cells, these proteins may differ depending on cell type, and their identification is beyond the scope of this manuscript. These considerations are now discussed in the revised manuscript (second Discussion section: "Hormonal remodelling of adult organs").

*Results and Discussion, third paragraph:* ovo^D1^---*this is an interesting set of results but, as far as I* can *tell, the authors did not include a fertile wildtype control for* ovo^D1^ *in this experiment, so the only statement* can *be made from this experiment is about non-mating versus mating. A properly controlled experiment should include 4 groups: WT control versus* ovo^D1^, *both mated versus unmated*.

We have conducted the experiments in these four groups as requested by the reviewer. The experiments confirm that both the increases in proliferation and midgut diameter and the activation of SREBP occur to a comparable degree in sterile and fertile flies, and are shown in [Figure 4figure supplement 1](#fig4s1){ref-type="fig"}, panels A to E.

*Results and Discussion, same paragraph: "might accumulate... peripheral fat stores in the absence of the local (ovary) sink". Two reactions to this statement: (1) we already know that in many animals sterility (gonadectomy, castratation) causes increased fat accumulation or obesity (cf.* [@bib30] *and references therein), (2) the* ovo^D1^ *mutants are, as far as I know, not properly ovary-less, they just have smaller ovaries than wild-type. Thus, with regard to (1) there is indeed published evidence for the authors' statement. Similarly, the important result in* [@bib88]*, that corpus allatum ablation impedes fat body development, should be cited and discussed. This result is consistent with the authors\' findings*.

We thank the reviewer for pointing out these relevant references. Point 1 is now discussed in the last section of the revised Discussion. Point 2 has been addressed by amending the sentence to "we used sterile *ovo*^*D1*^ females to quantify lipid content, reasoning that it might accumulate in gut and/or peripheral fat stores in the absence of the local ovarian sink" in the revised Results section "Mating-triggered intestinal remodelling maximises reproductive output". We have also mentioned the effect of JH on the fat body reported by Yamamoto et al. (in the second section of the revised Discussion).

*Results and Discussion: (Endcrine regulation of) Organ size plasticity in* Drosophila*---the authors should cite the papers by Alexander Shingleton here*.

The papers by Alex Shingleton are very nice and a couple of them have been cited elsewhere in the manuscript but, to our knowledge, none of them have shown plasticity in adult organs (as in post-eclosion changes in organ size that do not arise during development).

*Results and Discussion, fourth paragraph, especially the last two sentences: this is interesting and well-written but perhaps a bit on the speculative side*.

We agree that it these ideas are speculative and, as such, we introduce them as "intriguing possibilities". Given that these are the final sentences of the manuscript, we feel that it is appropriate to propose hypotheses and future research directions, and would like to retain them.

*In the figure legend for* [*Figure 1*](#fig1){ref-type="fig"} *and elsewhere: what is a negative binomial ANOVA? By definition an ANOVA is general (not a generalized) linear model which assumes a normal distribution of the errors/residuals. Here the authors seem to have used a generalized linear model with a negative binomial error structure, but I cannot be sure. Please clarify*.

We apologise for this mistake. Because pH3 experiments yielded count (discrete) data with a distinctly non-normal distribution, we fitted these data with a negative binomial generalised linear model (R function glm.nb from MASS package), which takes into account the asymmetric nature and overdispersion of count values (Bliss and Fisher (1953) Biometrics 9, 176--200), and then used likelihood ratio tests (R function anova.negbin from MASS package) to obtain p values. We have explained this analysis in Materials and methods (under "Statistics and Figure Preparation") and have replaced ANOVA with GLM in the relevant figure legends.

*In general: In some of their experiments, the authors have used TLC and a (semi-quantitative) quantification of TLC to assess peripheral fat. Why did the authors not use one of the well-established and commercially available kit-based TAG assays*?

The kit-based TAG assays are subject to experimental error from two sources:

1\) Pigmentation from the eyes or cuticle in the extract can contribute to the colorimetric read-out used for kit-based assays.

2\) The kits do not strictly measure TAGs alone. The enzymatic reaction used to produce the colour signal also cleaves other molecules with glycerol backbones such as diacylglycerides and monoacylglycerides. Thus, by using a kit, the colorimetric signal would reflect released glycerol from TAGs as well as other glycerides.

TLC used under the conditions described in the manuscript is capable of separating TAGs from other classes of glycero-lipids. Pigmentation also does not contribute to the TAG signal since the pigments do not have the same retention index (i.e., they do not migrate in the same band) as TAGs.

Previous work comparing commercial kits to TLC for TAG quantitation found the latter to be less sensitive and less accurate. For details see Al-Anzi et al. (2010) PLoS One (doi: 10.1371/journal.pone.0012353).

*In the subsection headed "Fly strains": I am worried that apparently none of the experiments has involved fully co-isogenic, backcrossed wild-type controls which are co-isogenic with the* Gal4 *and UAS-RNAi lines used. I think this is probably not a big concern for the majority of experiments, but this might play a role for the fecundity assays since this trait is notoriously quantitative and sensitive to genetic background*.

We agree that fecundity is very sensitive to genetic background, which is why we avoid working with isogenic genetic backgrounds that might give phenotypes that cannot be replicated in other genetic backgrounds. For this reason, we opted for testing fecundity in different genetic backgrounds with their appropriate controls. Between [Figure 4E, F](#fig4){ref-type="fig"} and [Figure 4--figure supplement 1F and G](#fig4s1){ref-type="fig"}, we tested 7 independent RNAi lines belonging to 3 different collections (VDRC KK, VDRC GD and TRIP, i.e. 3 different genetic backgrounds), and used genetically matched controls for each collection (for example, for the TRiP RNAi lines, *UAS* control flies were genetically matched and contained an equivalent valium10 *UAS* vector containing the *GFP* coding sequence inserted into the same site as the hairpin construct in the TRiP RNAi lines, the attp2 site). This is now explicitly stated in the Materials and methods section under "Fly strains".

*In the subsection headed "Fly strains" and following: did the authors verify the efficiency of RNAi silencing* via *qRT-PCR? The fact that many manipulations did have phenotypic effects suggests that RNAi has worked but this is of course no proof. In general, I think that if one uses RNAi one should demonstrate that it has indeed reduced mRNA transcript (or even better protein levels)*.

We have verified that the RNAi transgenes KK100638 and KK101814 downregulate *Met* and *gce* transcripts respectively using qPCR, as requested by the reviewer. This data is now shown in [Figure 3--figure supplement 1](#fig3s1){ref-type="fig"}, panel B. We also provide qPCR data showing downregulation of *Kr-h1* (KK107935) and SREBP (GD37640 and TRiP34073). This data is now shown in [Figure 3--figure supplement 1](#fig3s1){ref-type="fig"}, panel K.

*In the subsection headed "Fly husbandry": methoprene*---*how was this dosage determined? Is the methoprene used the pure enantiomere or a racemic mixture of s- and r-methoprene? More details on the product from Sigma should be given*.

Regarding dosage: this concentration was chosen in a pilot dilution test from 0.5 to 7.5 mM as the one which induced activation of the *SREBP-Gal4* reporter to levels comparable to mating, and corresponds to approximately half of the concentration used in a previous study ([@bib23] Evolution). This is now clearly stated under Fly Husbandry in Materials and methods. Re: the chemical nature of the methoprene used. Although the Sigma product sheet does not specific whether their methoprene is pure or a racemic mixture, we have checked with Sigma, who has confirmed that it is the racemic mixture. These details and the Sigma product number have been provided in the revised Materials and methods under "Fly husbandry".

*In the subsection headed "Detection of circulating JH hormone by DART-MS": synthetic JH III---I am not aware that there is synthetic JH III but I may of course be wrong. Is this not simply proper JH III isolated from Manduca sexta*?

No information is given in the product sheet from Santa Cruz Biotechnology so we have replaced "synthetic JHIII" with "a JHIII standard", and provide details of product number as well as source in the revised Materials and methods under "Detection of circulating JH hormone by DART-MS".

*In the subsection headed "Fertility and fecundity experiments" and following: I failed to find the fertility experimental data---where are these? Note (see my comment above) that viability is* not *the same as fertility*.

As mentioned earlier, in addition to testing egg production, we have also tested egg viability in a subset of experiments, and have included these data in the revised manuscript in [Figure 4--figure supplement 1](#fig4s1){ref-type="fig"} (panels H and I). As requested by the reviewer, we have also amended all references to fertility throughout the manuscript, either replacing them with terms such as "progeny viability" in our experiments and in the Materials and methods section, or explaining the concept further in the revised Introduction and Discussion (e.g. "lifetime fertility" or "at the time of peak fertility").

*I am also a bit worried about the temperature shift effects on fecundity: this is rather unnatural. Of course I see the reason for doing this but: (1) were there no GeneSwitch-*Gal4 *constructs available that could have been used to restrict silencing to the adult stage? (2) were the (wildtype) controls in these experiments also subjected to the temperature shift? Finally, as mentioned above, measuring fecundity over 6 days may not be a good, accurate predictor of (lifetime) reproductive success*.

In our experience, the RU486 ligand used to activate GeneSwitch constructs can also have other effects, independent of the transgene. Depending on the genetic background, RU486 feeding of control flies causes variability in egg laying and lifespan. Indeed, concerns regarding RU effects in mated female flies in particular have been recently reported (Landis et al. (2015) Aging 7(1):53--69), and may well stem from RU interfering with this intestinal remodelling. For these reasons, we favour the use of adult-specific, temperature -inducible downregulations. In response to the reviewer's question, absolutely, the controls are also subjected to the same temperature shifts. This is now clearly stated in the revised Materials and methods under "Fly husbandry". Finally, the point regarding reproductive success has also been addressed as described earlier.

*In the subsection headed "Statistics and figure preparation": I am confused about "assuming unequal deviances". Do the authors mean "variances"? "Deviances" is* not *the same as variances; deviances have a special statistical meaning which does not make sense in the context of a* t*-test. And "assuming unequal" variances does not make sense either: a* t*-test assumes normality of residuals and equal variances. Nonetheless, there is in fact a* t*-test which does not require the assumption of equal variances, the Welch* t*-test or Welch-ANOVA, but I am not sure the authors have used this*.

We apologise for this mistake. We did indeed mean variances and the test did include Welch's correction. This has now been amended in the "Statistics and figure preparation" of the revised Materials and methods.

[*Figure 4*A](#fig4){ref-type="fig"} *strikes me as being unnecessary.*

We agree that readers who are familiar with the anatomy of adult *Drosophila* may find this figure panel unnecessary, but it may help non-*Drosophila* researchers interpret the experiments related to the intestinal effects on egg production. For this reason, we would like to retain it.

*Reviewer \#2 minor comments*:

*1) The expression patterns of the* Gal4 *drivers need to be described somewhat better (preferably in brief in the main text) and supporting citations or results given. This includes* Mex-, Aug21*- and* esgReDDM-Gal4.

These are now described when first used in the revised Results section, and each mention is followed by the relevant reference.

*2) In* [*Figures 2B and 3D*](#fig2 fig3){ref-type="fig"} *the authors have not measured SREBP "activity" as it states in the figure, but levels. Please correct this*.

The SREBP reporter used in [Figures 2A and 3C](#fig2 fig3){ref-type="fig"} is unusual in that, rather than reporting gene expression like most *Gal4* drivers, is only turned on in cells in which SREBP is proteolytically processed and therefore active (see [@bib41] Cell metabolism 3, 439--448 for details). So by quantifying GFP levels, as the Y axis of the graph shows ("Ranked GFP levels"), we obtain information about activity. We feel that it is important to highlight that we are visualising activity in the image heading so as to distinguish it from transcript levels, which we have also quantified (e.g. [Figure 2E,F](#fig2){ref-type="fig"}). However, we acknowledge that it can be confusing and, for this reason, we are providing a more detailed explanation including the Kunte et al. reference in both the revised Results section and the legend of [Figure 2](#fig2){ref-type="fig"}.
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